Literature DB >> 1908060

Failure of prophylaxis with dapsone in patients taking dideoxyinosine.

C E Metroka, M F McMechan, R Andrada, L J Laubenstein, D P Jacobus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1908060     DOI： 10.1056/nejm199109053251014

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  Adverse effects and drug interactions of medications commonly used in the treatment of adult HIV positive patients.

Authors:  R Heylen; R Miller
Journal:  Genitourin Med       Date:  1996-08

2.  Levels of dapsone and pyrimethamine in serum during once-weekly dosing for prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.

Authors:  M Opravil; B Joos; R Lüthy
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

3.  Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.

Authors:  J Falloon; J Lavelle; D Ogata-Arakaki; A Byrne; A Graziani; A Morgan; M A Amantea; K Ownby; M Polis; R T Davey
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

Review 4.  Drug interactions with antiviral drugs.

Authors:  A M Taburet; E Singlas
Journal:  Clin Pharmacokinet       Date:  1996-05       Impact factor: 6.447

Review 5.  Didanosine. A review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection.

Authors:  D Faulds; R N Brogden
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

6.  Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in patients with the acquired immunodeficiency syndrome.

Authors:  M Barry; J L Howe; S Ormesher; D J Back; A M Breckenridge; C Bergin; F Mulcahy; N Beeching; F Nye
Journal:  Br J Clin Pharmacol       Date:  1994-05       Impact factor: 4.335

7.  Evaluation of effects of altered gastric pH on absorption of dapsone in healthy volunteers.

Authors:  G A Breen; J M Brocavich; J V Etzel; V Shah; P Schaefer; S Forlenza
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

Review 8.  Pharmacokinetic drug interactions with antimicrobial agents.

Authors:  J G Gillum; D S Israel; R E Polk
Journal:  Clin Pharmacokinet       Date:  1993-12       Impact factor: 6.447

9.  Pharmacokinetics of dapsone in human immunodeficiency virus-infected children.

Authors:  G Gatti; A Loy; R Casazza; F Miletich; M Cruciani; D Bassetti
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.